Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.77%
|
-
|
|
Oct 03
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+1.97%
|
-
|
|
Sep 20
2022
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
108
+0.14%
|
-
|
|
Sep 20
2022
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.15%
|
-
|
|
Sep 20
2022
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.06%
|
-
|
|
Sep 20
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.04%
|
-
|
|
Sep 20
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.33%
|
-
|
|
Sep 20
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.31%
|
-
|
|
Sep 20
2022
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
58
+0.12%
|
-
|
|
Sep 20
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.32%
|
-
|
|
Sep 20
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.14%
|
-
|
|
Sep 20
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
108
+0.29%
|
-
|
|
Sep 20
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.0%
|
-
|
|
Sep 20
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.04%
|
-
|
|
Sep 20
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.26%
|
-
|
|
Sep 20
2022
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.3%
|
-
|
|
Aug 26
2022
|
Thomas E Roos Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
465
-1.32%
|
$252,030
$542.37 P/Share
|
|
Aug 26
2022
|
Thomas E Roos Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
465
-1.3%
|
-
|
|
Aug 18
2022
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Open market or private sale
|
Direct |
14,715
-22.7%
|
$7,990,245
$543.32 P/Share
|
|
Aug 12
2022
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-0.98%
|
$133,578
$543.7 P/Share
|
|
Jul 29
2022
|
John F Rex President & CFO |
SELL
Open market or private sale
|
Direct |
13,183
-8.52%
|
$7,132,003
$541.53 P/Share
|
|
Jul 29
2022
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,982
-13.9%
|
$13,465,298
$539.37 P/Share
|
|
Jul 29
2022
|
John F Rex President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,757
+19.94%
|
$3,132,990
$70.24 P/Share
|
|
Jul 26
2022
|
Stephen J Hemsley Director |
SELL
Open market or private sale
|
Direct |
99,312
-11.2%
|
$53,032,608
$534.27 P/Share
|
|
Jul 26
2022
|
Stephen J Hemsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
99,312
+10.07%
|
$5,660,784
$57.38 P/Share
|
|
Jul 18
2022
|
Andrew Witty CEO, UHG |
SELL
Open market or private sale
|
Direct |
11,376
-12.94%
|
$5,995,152
$527.9 P/Share
|
|
Jul 01
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+2.01%
|
-
|
|
Jul 01
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.93%
|
-
|
|
Jul 01
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+0.04%
|
-
|
|
Jul 01
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.27%
|
-
|
|
Jul 01
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
172
+1.49%
|
-
|
|
Jul 01
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+2.09%
|
-
|
|
Jul 01
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+4.56%
|
-
|
|
Jun 28
2022
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.3%
|
-
|
|
Jun 28
2022
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.09%
|
-
|
|
Jun 28
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.32%
|
-
|
|
Jun 28
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
60
+0.04%
|
-
|
|
Jun 28
2022
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.06%
|
-
|
|
Jun 28
2022
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.16%
|
-
|
|
Jun 28
2022
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
111
+0.13%
|
-
|
|
Jun 28
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.27%
|
-
|
|
Jun 28
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.04%
|
-
|
|
Jun 28
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.29%
|
-
|
|
Jun 28
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.14%
|
-
|
|
Jun 28
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.33%
|
-
|
|
Jun 28
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.32%
|
-
|
|
Jun 28
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.0%
|
-
|
|
Jun 24
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
0
|
$0
$492.75 P/Share
|
|
Jun 23
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,273
-13.58%
|
$635,227
$499.0 P/Share
|
|
Jun 07
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.32%
|
$62,125
$497.1 P/Share
|